A Speech Recognition Application as a Communication Aid for Acute and Critical Care Patients With Tracheostomies
Launched by QUEEN'S UNIVERSITY, BELFAST · Aug 30, 2023
Trial Information
Current as of July 23, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a new communication aid designed for patients who have had a tracheostomy, which is a procedure that involves creating an opening in the neck to help with breathing. Because this procedure can prevent patients from speaking, it can be very difficult for them to express their needs or feelings. The trial will test a device that uses a smartphone or tablet to read lip movements and turn them into text on the screen, making it easier for patients to communicate with doctors, nurses, and family members.
To participate in this study, individuals must be 18 years or older, have recently undergone a tracheostomy, and be able to move their lips to form words. They also need to be able to communicate in English. The study will take place in several critical care units in Northern Ireland and will last for about 18 months. Participants will have the chance to use the lip-reading device, share their experiences through interviews, and answer follow-up questions about their health a few months after leaving the hospital. This research is important because it aims to improve communication for patients who may feel isolated and stressed due to their inability to speak.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients aged 18 years and over
- • Patients who acquire a tracheostomy in acute/critical care
- • Patients can move lips in a way that articulates words
- • Able to communicate in English (a current requirement of the technology)
- Exclusion Criteria:
- • -Patient declined consent
About Queen's University, Belfast
Queen's University Belfast is a prestigious research institution located in Northern Ireland, renowned for its commitment to advancing knowledge and improving health outcomes through innovative clinical research. The university actively engages in a diverse range of clinical trials, focusing on translational medicine and interdisciplinary collaboration to address pressing health challenges. With a strong emphasis on ethical standards and patient safety, Queen's University Belfast leverages its state-of-the-art facilities and a team of experienced researchers to contribute to the development of new therapies and enhance the understanding of various medical conditions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Belfast, Northern Ireland, United Kingdom
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported